CHRISTOPHER CAPPS: Open Payments
NPI 1437629136 · KOKOMO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,485 in 60 payments from 22 companies in 2025. Trend: 2023 $1,651 · 2024 $1,932 · 2025 $1,485
Food & beverage: $1,396Education: $89
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $309 |
| Novartis Pharmaceuticals Corporation | 13 | $256 |
| Actelion Pharmaceuticals US, Inc. | 4 | $140 |
| Amgen Inc. | 6 | $101 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $92 |
| Kestra Medical Technology Services, Inc. | 3 | $67 |
| SCPHARMACEUTICALS INC. | 2 | $53 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Merck Sharp & Dohme LLC | 3 | $48 |
| Regeneron Healthcare Solutions, Inc. | 2 | $45 |
Products named: CARDIOMEMS, LEQVIO, OPSUMIT, REPATHA, JARDIANCE, ELIQUIS, Assure WCD, FUROSCIX.
Industry payments across IN — which companies pay providers there.
